Healthpeak Properties, Inc. announced that its Board of Directors (the "Board") has appointed Scott Brinker, the Company's President and Chief Investment Officer, as President and elected him to the Healthpeak Board, effective immediately. Mr. Brinker succeeds Tom Herzog, who mutually agreed with the Board to step down as Chief Executive Officer and from the Board to pursue other endeavors. Healthpeak also announced that Scott Bohn, Executive Vice President – Co-Head of Life Science, was appointed Chief Development Officer, in addition to retaining his role as Co-Head of Life Science, and Adam Mabry, previously Senior Vice President – Investments, was promoted to Chief Investment Officer.

Mr. Bohn has served as Executive Vice President – Co-Head of Life Science since February 2022, previously serving as Senior Vice President – Co-Head of Life Science. Prior to joining the Company in 2012, he held various development, acquisition and leasing positions at Terreno Realty Corporation, AMB Property Corporation and RREEF/Deutsche Bank. Mr. Mabry, a CFA charterholder, has served as Senior Vice President – Investments since September 2018, previously serving as Senior Vice President – Corporate Transactions from February 2018 to September 2018, and Vice President – Corporate Transactions from June 2017 to January 2018.

Prior to joining Healthpeak, he was a Vice President at The Wolff Company and a Vice President at Barclays in the real estate investment banking group.